Meeting Banner
Abstract #2901

Discriminate glioblastoma recurrence versus radionecrosis: consider cerebrovascular reactivity mapping

Marco Piccirelli1, Giovanni Muscas1, Christiaan Hendrik Bas van Niftrik1, Nicolaus Andratschke1, Michelle Leanne Brown1, Oliver Bozinov1, Luca Regli1, Christoph Stippich1, and Jorn Fierstra1

1University Hospital Zurich, Zurich, Switzerland

Exploiting the different vascular pathophysiology in brain glioblastomas compared to radionecrosis, we aim to improve the differential diagnosis of post-treatment contrast-enhancing lesions. To recognize recurrent glioblastoma after treatment, we investigate if relevant CVR differences exist between newly diagnosed brain glioblastomas and radionecrosis. For this purpose, we utilized blood oxygenation-level-dependent functional MRI (BOLD-fMRI) to study CVR.

This abstract and the presentation materials are available to members only; a login is required.

Join Here